TY  - GEN
AU  - Hopkins,S
AU  - Lambourne,J
AU  - Farrell,G
AU  - McCullagh,L
AU  - Hennessy,M
AU  - Clarke,S
AU  - Mulcahy,F
AU  - Bergin,C
TI  - Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals
SN  - 1464-2662
PY  - 2006///1109
KW  - Adult
KW  - Antiretroviral Therapy, Highly Active
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Blood Cell Count
KW  - CD4 Lymphocyte Count
KW  - Drug Administration Schedule
KW  - Drug Carriers
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - HIV Infections
KW  - blood
KW  - Hepacivirus
KW  - isolation & purification
KW  - Hepatitis C
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Mental Disorders
KW  - chemically induced
KW  - Polyethylene Glycols
KW  - Prospective Studies
KW  - RNA, Viral
KW  - analysis
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1468-1293.2006.00365.x
ER  -